Deborah A. Knight

Tumor immune evasion arises through loss of TNF sensitivity

Conor J. Kearney, Stephin J. Vervoort, Simon J. Hogg et al. · Science Immunology · 2018 · 393 citations

Life Sciences, Cancer Biology, Immunology +12

NOVEL MECHANISM OF INHIBITION OF CYTOMEGALOVIRUS BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1,2

W. James Waldman, Deborah A. Knight, Nell S. Lurain et al. · Transplantation · 1999 · 143 citations

Medicine, Infectious Diseases, Pharmacology +17

Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors

Michaela Waibel, Vanessa S. Solomon, Deborah A. Knight et al. · Cell Reports · 2013 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

Bidirectional Transmission of Infectious Cytomegalovirus between Monocytes and Vascular Endothelial Cells: An In Vitro Model

W. James Waldman, Deborah A. Knight, Emina H. Huang et al. · The Journal of Infectious Diseases · 1995 · 128 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

A role for CCL2 in both tumor progression and immunosurveillance

Ming Li, Deborah A. Knight, Linda A. Snyder et al. · OncoImmunology · 2013 · 126 citations · Full text

Medicine, Immunology, Oncology +17